EUVIMEDEUVIMED entdecken
Crossref

Molecular Epigenetic Modulation of Immune Tolerance in Graves' Disease: The Role of Short-Chain Fatty Acids in the Regulation of TRAb Synthesis

R. M. Gabibullaev, A. A. Udagova, S. A. Ibragimova, L. R. Khorava, V. A. Prokurorova, R. A. Azizova, H. A. Alikhanova, E. I. Merzhoeva, Ya. E. Maltseva, Ya. E. Simakova, A. A. Pak

Clinical and experimental thyroidology · 16.06.2026 · 21 (3) · 23-31

DOI: 10.14341/ket12851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and experimental thyroidology, online erschienen am 16.06.2026. Verfasst von R. M. Gabibullaev und 10 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graves’ disease is a systemic autoimmune process characterized by persistent breakdown of immune tolerance and continued presence of thyrotropin receptor autoantibodies (TRAb), even after radical thyroidectomy. This review examines the role of the “gut–thyroid axis” as a key regulator of systemic immune homeostasis. Particular attention is paid to short-chain fatty acids (SCFAs) — microbial metabolites that act as potent epigenetic modulators. The mechanisms of histone deacetylase (HDAC) inhibition by butyrate and propionate are described in detail, which promote stabilization of Foxp3 gene expression in regulatory T cells and suppression of B-lymphocyte differentiation factors (AID, Blimp-1). The interplay between intestinal dysbiosis, increased barrier permeability, and uncontrolled autoantibody production is analyzed. In conclusion, prospective targeted therapeutic strategies are discussed, fecal microbiota transplantation (FMT), and the use selective HDAC inhibitors aimed at restoring immune control in refractory forms of the disease.

Zitieren

APA

Gabibullaev, R. M., Udagova, A. A., Ibragimova, S. A., Khorava, L. R., Prokurorova, V. A., Azizova, R. A., Alikhanova, H. A., Merzhoeva, E. I., Maltseva, Y. E., Simakova, Y. E., & Pak, A. A. (2026). Molecular Epigenetic Modulation of Immune Tolerance in Graves' Disease: The Role of Short-Chain Fatty Acids in the Regulation of TRAb Synthesis. Clinical and experimental thyroidology, 21(3), 23-31. https://doi.org/10.14341/ket12851

Vancouver

Gabibullaev RM, Udagova AA, Ibragimova SA, Khorava LR, Prokurorova VA, Azizova RA, et al. Molecular Epigenetic Modulation of Immune Tolerance in Graves' Disease: The Role of Short-Chain Fatty Acids in the Regulation of TRAb Synthesis. Clinical and experimental thyroidology. 2026;21(3):23-31. doi:10.14341/ket12851

BibTeX
@article{Gabibullaev2026,
  author = {Gabibullaev, R. M. and Udagova, A. A. and Ibragimova, S. A. and Khorava, L. R. and Prokurorova, V. A. and Azizova, R. A. and Alikhanova, H. A. and Merzhoeva, E. I. and Maltseva, Ya. E. and Simakova, Ya. E. and Pak, A. A.},
  title = {Molecular Epigenetic Modulation of Immune Tolerance in Graves' Disease: The Role of Short-Chain Fatty Acids in the Regulation of TRAb Synthesis},
  journal = {Clinical and experimental thyroidology},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {23--31},
  doi = {10.14341/ket12851}
}
Kostenlos starten →